print_label | resize_label

Partnering

Spirogen PBD Research Collaborations & Partnerships1

COMPANY YEAR DESCRIPTION
GamaMabs Pharma 2017 License to develop PBD ADCs
Regeneron Pharmaceuticals 2016 License to develop PBD ADCs
Mitsubishi Tanabe Pharma (MTPC) 2015 License to develop PBD ADCs
AstraZeneca/MedImmune 2013 Acquisition
AstraZeneca/MedImmune 2013 License to develop PBD ADCs
Kolltan Pharmaceuticals 2013 License to develop PBD ADCs
ADC Therapeutics 2012 License to develop specific ADC programs
Genentech 2011 License and multi-year research collaboration
Auven Therapeutics 2009 Option to acquire SG2000 post-P2
Seattle Genetics 2008 License to develop PBD ADCs

1Publicly disclosed